Back

Glycated haemoglobin and risk of all-cause, causal mortality and cardiovascular hospitalisation in type 2 diabetes mellitus according to body mass index.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Diabetes, obesity and metabolic syndrome Metabolic Syndrome, Insulin, Insulin Resistance ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Oliver Ian Brown

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

10 More presentations in this session

Presentation thumbnail
Baseline insulin levels are associated with need for revascularization among diabetic patients with high risk vascular disease: insights from the ACCELERATE trial
Doctor V. Menon (Cleveland, US)
Abstract
Presentation thumbnail
Regional differences in the incidence of acute coronary syndrome and ischemic stroke in diabetic populations reflect differences in the quality of diabetes care
Doctor K. Winell (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Protein oxidation and cardiovascular disease in patients with type 2 diabetes.
Miss A. Bryk (Krakow, PL)
Abstract
Presentation thumbnail
Severity of retinopathy and coronary artery calcium score in type 1 and type 2 diabetic patients
Doctor G. Achkouty (Jdeide, Metn, LB)
Abstract Slides
Presentation thumbnail
Isolated systolic hypertension and combined systolic-diastolic hypertension for prediction of new-onset diabetes mellitus: Data from a 8-year-follow-up study
Doctor D. Konstantinidis (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Diabetes, obesity and metabolic syndrome

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources